Survival for older patients with acute myeloid leukemia: a population-based study - Wikidata - wikimedia - TriplyDB

Survival for older patients with acute myeloid leukemia: a population-based study

Survival for older patients with acute myeloid leukemia: a population-based study

http://www.wikidata.org/entity/Q36662052

about

Defining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive Therapies Aberrant splicing and drug resistance in AML Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades.Interpreting outcome data in hematopoietic cell transplantation for leukemia: tackling common biases.Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc.Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).CD30 expression in high-risk acute myeloid leukemia and myelodysplastic syndromes Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysis Management of older or unfit patients with acute myeloid leukemia Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States.The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma.Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML)Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life The benefit of population-based studies for older patients with acute myeloid leukemia Outcomes of Allogeneic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-analysis.Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications The value of molecular stratification for CEBPA(DM) and NPM1(MUT) FLT3(WT) genotypes in older patients with acute myeloid leukaemia Metronomic therapy with oral 6-mercaptopurine in elderly acute myeloid leukemia: A prospective pilot study.Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study.Decitabine in the treatment of acute myeloid leukemia in elderly patients.Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience.Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.Outpatient care of patients with acute myeloid leukemia: Benefits, barriers, and future considerations Lenalidomide as a novel treatment of acute myeloid leukemia.Emerging immunotherapies in older adults with acute myeloid leukemia.Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century.Acute myeloid leukemia and myelodysplastic syndromes in older adults.An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia.Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients.Elderly acute myeloid leukemia: assessing risk.Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly.

P2860

Q26772235-F702C9A1-DA3B-4E57-ADA5-13B83446F857 Q28076011-84F1CEE1-FEAC-4530-8548-BBF78C6F925F Q30620658-E4D56A04-5FC3-42BF-AEE8-F223E6F77665 Q30884173-BD8BF707-5148-4341-9A42-1D59D0BC0B5C Q31163049-85A36F62-DF6D-40EC-83E0-30BF116FBFB5 Q31164546-3FE1B2C0-01FA-4778-BC1F-C040FD03546D Q33859061-3C63F691-7B33-43EA-AAEC-68EB189560E7 Q33978945-DEDF243A-E87D-45F4-9CE5-FB1847DC13A9 Q34276134-C640A2B7-9A53-43D9-973B-3CE35AFFE392 Q34300698-4F2214DC-4209-4B00-9238-87125461043A Q34428556-31AFA7A3-0659-4364-AD3B-FD0FF0CE857A Q34893307-E2F31008-7AAA-47F4-9B16-44D14FCE4524 Q35581741-FD5A1C2F-965E-4D4F-82BE-C5EBB9962530 Q35832484-68294EA8-7DDB-47F0-9A2C-63C05D1DB179 Q35859212-E459BBAC-5954-4B8C-A311-B9B7359F0E31 Q36009600-037E4C2C-A3E1-4C4D-9FD5-E5240A0CE9D4 Q36563582-EF5D9193-DABB-45A2-9723-3BFA5ED569B8 Q36623075-743AACC8-BBC4-47A2-A435-C956FF9061A8 Q36633055-BC5690A8-6C65-4F17-B7FE-5EBBC0927125 Q36662009-32FDF366-259A-4EEA-8861-2695BAB70E7C Q36723291-FA5E6F13-DB94-4933-8928-E16093341A96 Q36804633-5109647F-5AC6-49DB-A63B-3D5BFFA455A5 Q36866323-4AB3B373-81D9-41DD-A2F8-D9C2111C140B Q36918925-B238FA81-CDE1-44F5-A3A0-E729D721DFCC Q36989586-D836D5EE-555D-4160-A52F-5E6CD41C2918 Q37036452-40CBA639-33BF-4670-A0C1-F99F7FC439D2 Q37568244-DFBAACBD-AFFA-4853-B553-8D2492AF8C90 Q37621352-C52B6CEA-E135-4CDB-894B-291424EBE14B Q37628931-480613A2-1B02-4B5F-9BC2-BED3C63B2C0D Q37740176-DD7FDA64-56AE-4717-825A-98921FD7A497 Q38073811-ADC68867-98BE-44F6-88A7-23BB7B3C47DE Q38075407-30AC8430-D7C4-4892-9DE9-A4FCFBC3B671 Q38091393-C6B819D4-9F61-4B9A-AFFF-A3F771F6D3F7 Q38104287-E36FD557-FB36-4806-A381-55B564584781 Q38234863-457855BA-CF4B-496D-9BE9-24D29468C06B Q38285621-6C774E2D-22A6-4861-9191-2C955E35EBC0 Q38436591-B04F1722-C3BE-44B5-8E3B-2BAFC019A977 Q38458166-3E906E61-DF62-46B5-815D-B797B3ABB2E4 Q38636162-92F4E6A1-5F02-48CC-9909-F06D1FF97AE0 Q38651372-B784C165-9E30-4BC1-BC5C-7590988E017F

P2860

Survival for older patients with acute myeloid leukemia: a population-based study

http://www.wikidata.org/entity/Q36662052

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Survival for older patients with acute myeloid leukemia: a population-based study

@ast

Survival for older patients with acute myeloid leukemia: a population-based study

@en

type

label

Survival for older patients with acute myeloid leukemia: a population-based study

@ast

Survival for older patients with acute myeloid leukemia: a population-based study

@en

prefLabel

Survival for older patients with acute myeloid leukemia: a population-based study

@ast

Survival for older patients with acute myeloid leukemia: a population-based study

@en

P1433

Q36662052-2A9B3E01-E4F4-4270-BED7-039BBC9F5945

P1476

Q36662052-53EB5279-7D81-4A2B-9D00-65211364C4BD

P2093

Q36662052-2B14C833-654B-4FB9-BCA8-875CB2213474

Q36662052-F6987799-32CB-4E71-82F3-FF153F67BC1F

P2860

Q36662052-06B11495-561E-495D-818A-0A3420068019

Q36662052-11F13B10-A516-44E5-89E4-20451A211234

Q36662052-127A2799-1405-4B58-871D-122385020385

Q36662052-12E42C57-AB6F-4779-BB34-EC77E680BEDA

Q36662052-15513FD2-B473-439A-A9D2-86C3459BB6E5

Q36662052-16BF20AB-96A2-47C1-9C7B-71BB48D6DBE8

Q36662052-29F43161-81B1-4E43-B0BF-7E372FE15C02

Q36662052-2B3F074A-98D4-4D73-A632-6940DFC7E292

Q36662052-2F08775C-3AF8-44C4-AFA3-77889CC5F489

Q36662052-5002ECE3-7B8B-434D-9278-3E89F0F15F48

P304

Q36662052-3F25F792-7C4C-4059-A4E9-F77F3D2561DF

P31

Q36662052-0153B35F-BB17-4319-A726-C59B739022E0

P356

Q36662052-F8758E36-950D-46AF-8C74-EBC8608A6FDE

P433

Q36662052-EC7BF011-4B1B-4E26-8892-1DE9C7DE6F3E

P478

Q36662052-23A69133-F16A-436E-B61B-5944DC10A702

P577

Q36662052-8124A765-0C13-4D1E-87D0-2BCF8A724A0B

P5875

Q36662052-E917214B-FD02-42DC-9B4E-C3C5D7EAA89D

P698

Q36662052-37A975C0-75E3-4E9E-BE21-65170717E853

P921

Q36662052-F23CB7D5-FEBB-486B-8E69-8CC85CE1737F

P932

Q36662052-99FE7CCD-399D-49FD-8A56-478D4CF8E551

P356

HAEMATOL.2012.066100

P1433

P1476

Survival for older patients with acute myeloid leukemia: a population-based study

@en

P2093

Betul Oran

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisdorf

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Development of a comorbidity index using physician claims data.

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial.

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland.

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

Acute myelogenous leukemia and aging. Clinical interactions.

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

P304

1916-1924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2012.066100

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228446811

http://www.w3.org/2001/XMLSchema#string

P698

22773600

http://www.w3.org/2001/XMLSchema#string

P921

P932

3590098

http://www.w3.org/2001/XMLSchema#string